Low-Dose Computed Tomographic Screening for Lung Cancer - 29/05/15
Résumé |
Low-dose computed tomographic (LDCT) screening is now moving from clinical trials to clinical practice, following the report from the National Lung Screening Trial that LDCT screening for lung cancer can reduce the number of deaths from lung cancer by 20% in current and former smokers, ages 55 to 74 years, with a 30 pack-year smoking history. This article reviews the current evidence for screening, key elements of a successful lung cancer screening clinic, and reporting and management guidelines for LDCT screening findings.
Le texte complet de cet article est disponible en PDF.Keywords : Computed tomography (CT), Lung cancer, Screening
Plan
| Disclosures: None. |
Vol 36 - N° 2
P. 147-160 - juin 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

